Tele-Navigation for Lung Cancer Screening

Overseen By Joann L Wagner, MSW

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: University of Massachusetts, Worcester

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: Unknown

22 Participants Needed

Trial Summary

What is the purpose of this trial?

Adherence to annual follow up is critical to achieving mortality benefits and optimizing cost-effectiveness of lung cancer screening (LCS). However, adherence to LCS follow-up in the real world is suboptimal. Using telehealth, the investigators will co-create Tele-Navigation of Lung Cancer Screening with patients and LCS stakeholders as an intervention to promote adherence of follow-up LCS. The investigators will then implement the Tele-Navi LCS intervention to a pilot sample of patients and evaluate its feasibility in the primary care setting. The investigators will measure the number of patient participants who completed Tele-Navi LCS and follow-up LCS within 180 days from Tele-Navi LCS.

Research Team

Mayuko Ito Fukunaga, MD

Principal Investigator

University of Massachusetts, Worcester

Eligibility Criteria

This trial is for English-speaking individuals who are eligible for and overdue a low-dose CT scan (LDCT) as part of lung cancer screening follow-up. Participants must have had their initial screening at UMMH and possess the technology to complete study activities, such as video calls. Those with a previous or active cancer diagnosis, nursing home residents, or pregnant individuals cannot join.

Inclusion Criteria

I speak English.

You are eligible for low-dose computed tomography (LDCT) for lung cancer screening follow-up.

I have had a lung cancer screening at UMMH.

Exclusion Criteria

I have been diagnosed with lung cancer before.

I currently have an active cancer diagnosis.

Is a nursing home or group care resident

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Tele-Navi LCS Intervention

Participants receive telehealth coaching from a Tele-Navigator for lung cancer screening

30 days

Telehealth sessions

Follow-up

Participants are monitored for adherence to follow-up lung cancer screening using low-dose CT

180 days

Treatment Details

Interventions

• Tele-Navi LCS

Trial Overview The Tele-Navi LCS intervention uses telehealth to improve adherence to follow-up lung cancer screenings. The study will create this program with patient input and test its feasibility in primary care by tracking if participants complete it and their subsequent LDCT within 180 days.

Participant Groups

Group I: Tele-Navi LCS Experimental Treatment 1 Intervention

Tele-Navi of LCS includes: telehealth coaching from a Tele-Navigator for patients undergoing LCS

Who Is Running the Clinical Trial?

University of Massachusetts, Worcester

Lead Sponsor

Trials

372

Recruited

998,000+

Meyers Primary Care Institute

Collaborator

Trials

1

Recruited

20+

Wake Forest University Health Sciences

Collaborator

Trials

1,432

Recruited

2,506,000+

National Institutes of Health (NIH)

Collaborator

Trials

2,896

Recruited

8,053,000+

National Cancer Institute (NCI)

Collaborator

Trials

14,080

Recruited

41,180,000+